USPTO serial 79097290
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, anti-bacterial, anti-diabetic, anti-viral, anti-sickness, anti-infective and cardiovascular treatment pharmaceuticals, anti-allergic pharmaceutical preparations, pharmaceutical preparations for the treatment of infectious diseases and disorders of the central nervous system, pharmaceutical preparations for hormonal deficiencies, erectile dysfunction and reproductive dysfunction, pharmaceutical preparations for use in oncology; veterinary preparations, namely, therapeutic anti-infective, anti-bacterial, anti-sickness and anti-allergic pharmaceuticals and therapeutic veterinary preparations, namely, pharmaceuticals for the treatment of infectious diseases, hormonal deficiencies and for use in oncology, all for livestock and domestic animals; sanitary preparations for medical purposes; dietetic foods adapted for medical use; material for stopping teeth; vaccines | SECTION 71 - CANCELLED | — |
| 010 | Surgical, medical, veterinary and dental devices, apparatus and instruments, namely, drug delivery systems, knives for surgical use, lasers for surgical and medical use, catheters for surgical use, and surgical and medical apparatus and instruments for use in general surgery; artificial limbs, eyes and teeth; orthopedic articles, namely, orthopedic apparatus and instruments for diagnostic and therapeutic use; suture materials | SECTION 71 - CANCELLED | — |
| 035 | Marketing services, namely, promoting or advertising the goods and services of others; marketing support services, namely, advertising and marketing of pharmaceutical and diagnostic preparations, therapeutics, medical apparatus, instruments and devices of third parties to enable them to be accepted and sold for worldwide distribution; creation of marketing partnerships between companies, namely, cooperative advertising and marketing of pharmaceutical companies as partners and their intellectual property licenses for the regulatory acceptance and sale of pharmaceuticals, medical apparatus, instruments and devices for worldwide distribution; advertising agencies; business development; consultation in the field of sales promotion services for business purposes; sourcing in the nature of procurement, namely, purchasing for others pharmaceutical products and medical apparatus, instruments and devices from third parties for worldwide distribution; import and export agencies; business auditing and preparation of business reports in the field of pharmaceutical products, and medical apparatus, instruments and device, for the purpose of regulatory guidance; executive recruiting services of management staff and personnel for pharmaceuticals and life sciences companies; business advisory and management services relating to company acquisitions and identifying and negotiating company acquisitions for third parties; business management and advisory services relating to obtaining marketing authorisations from relevant governing authorities in respect of pharmaceutical products, medical apparatus, instruments and devices; computerised database management; compilation and systemization of information into computer databases; commercial information agencies featuring a computer database; all of the aforesaid also provided online via the Internet or other interactive electronic platforms; information, advisory and consultancy services relating to all of the aforesaid | SECTION 71 - CANCELLED | — |
| 039 | Warehousing services, namely, storage, distribution, pick-up, packing, and shipping of pharmaceutical products and medical apparatus, instruments and devices; information, advisory and consultancy services relating to the aforesaid | SECTION 71 - CANCELLED | — |
| 045 | Licensing of pharmaceutical products; licensing of intellectual property for research and development purposes; licensing of intellectual property relating to pharmaceutical products, medical apparatus, instruments and devices; providing regulatory compliance information in the field of pharmaceuticals, medical devices, apparatus and instruments; information, advisory and consultancy services relating to all of the aforesaid | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 11, 2021 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Nov 11, 2021 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Nov 2, 2021 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Nov 2, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Nov 30, 2019 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 28, 2019 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 28, 2019 | INPC | INVALIDATION PROCESSED | — |
| Jun 5, 2019 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 5, 2018 | C71T | CANCELLED SECTION 71 | — |
| Feb 28, 2017 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 20, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 26, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 14, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 13, 2013 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 15, 2012 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 19, 2012 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 19, 2012 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 1, 2012 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 28, 2012 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 28, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 13, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 13, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 23, 2011 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 23, 2011 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 23, 2011 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 4, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 4, 2011 | ALIE | ASSIGNED TO LIE | — |
| Oct 9, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 14, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 14, 2011 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 14, 2011 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 14, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 20, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 19, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 19, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 4, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 14, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 13, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 13, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 12, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 11, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 10, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 9, 2011 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jun 9, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |